Literature DB >> 19191139

Association of serum leptin and adiponectin with obesity in asthmatics.

An-Soo Jang1, Tae-Hoon Kim, Jong-Sook Park, Ki-Up Kim, Soo-Taek Uh, Ki-Hyun Seo, Young Hoon Kim, Gune-Il Lim, Choon-Sik Park.   

Abstract

BACKGROUND: Mounting evidence implicates obesity as a major risk factor for asthma. Leptin and adiponectin produced by fat tissues play a critical role in the regulation of body weight and allergic inflammation.
OBJECTIVE: The aim of this study was to evaluate the effects of leptin and adiponectin on development of asthma.
METHODS: We measured the leptin and adiponectin in serum from patients with asthma (n = 60) and normal control subjects (n = 30) by enzyme-linked immunosorbent assay.
RESULTS: Logarithmic leptin and adiponectin concentration was not different between asthmatics and control subjects. Although the logarithmic adiponectin level was not different by gender in asthmatics, the logarithmic leptin concentration was significantly higher in females than in male asthmatics (2.41 +/- 0.05 ng/mL vs. 2.01 +/- 0.05 ng/mL, p = 0.001). The leptin/adiponectin ratio was also significantly higher in females than in male asthmatics. The leptin/adiponectin ratio was correlated with body mass index (r = 0.210, p = 0.05) in asthmatics.
CONCLUSION: Our results suggest that serum leptin and adiponectin may be associated with gender and obesity regardless of development of asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191139     DOI: 10.1080/02770900802444203

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  13 in total

Review 1.  Leptin, adiponectin and pulmonary diseases.

Authors:  Nour Ali Assad; Akshay Sood
Journal:  Biochimie       Date:  2012-03-14       Impact factor: 4.079

Review 2.  Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases.

Authors:  Juanita H J Vernooy; Niki D J Ubags; Guy G Brusselle; Jan Tavernier; Benjamin T Suratt; Guy F Joos; Emiel F M Wouters; Ken R Bracke
Journal:  Pulm Pharmacol Ther       Date:  2013-03-27       Impact factor: 3.410

Review 3.  Adiponectin in pulmonary disease and critically ill patients.

Authors:  P Garcia; A Sood
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Associations of asthma with body mass index and adult weight change among reproductive age women.

Authors:  Neway Gessesse Fida; Daniel A Enquobahrie; Bizu Gelaye; Chunfang Qiu; Michelle A Williams
Journal:  J Asthma       Date:  2011-09       Impact factor: 2.515

5.  Metformin prevents airway hyperreactivity in rats with dietary obesity.

Authors:  Gina N Calco; Becky J Proskocil; David B Jacoby; Allison D Fryer; Zhenying Nie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 6.011

Review 6.  Does obesity produce a distinct asthma phenotype?

Authors:  Njira L Lugogo; Monica Kraft; Anne E Dixon
Journal:  J Appl Physiol (1985)       Date:  2009-10-29

7.  Calorie restriction with a high-fat diet effectively attenuated inflammatory response and oxidative stress-related markers in obese tissues of the high diet fed rats.

Authors:  Seungae Park; Na-Young Park; Giuseppe Valacchi; Yunsook Lim
Journal:  Mediators Inflamm       Date:  2012-06-19       Impact factor: 4.711

8.  Trajectories of adiposity indicators and association with asthma and lung function in urban minority children.

Authors:  Stephanie Lovinsky-Desir; Stephanie J Lussier; Agustin Calatroni; Peter J Gergen; Katherine Rivera-Spoljaric; Leonard B Bacharier; Aliva De; George T O'Connor; Megan T Sandel; Robert A Wood; Emilio Arteaga-Solis; James E Gern; Meyer Kattan
Journal:  J Allergy Clin Immunol       Date:  2021-06-22       Impact factor: 10.793

Review 9.  Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies.

Authors:  Akshay Sood; Stephanie A Shore
Journal:  J Allergy (Cairo)       Date:  2013-10-30

Review 10.  Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma.

Authors:  Pinja Ilmarinen; Leena E Tuomisto; Hannu Kankaanranta
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.